General

Direct-to-Patient (DTP) models are evolving fast.

January 29, 2026

Back to insights

Today, ~10 manufacturers have already launched DTP capabilities to navigate new policy, access and competitive pressures. Our deep dive reveals that DTP means different things depending on therapeutic area, patient and access pathways.

VSHG’s latest DTP Landscape & Strategic Overview provides the clarity your team needs to understand what’s happening and what it takes to participate effectively.

Our service explores:

  • Evolving DTP structures and platform characteristics
  • Integration with telehealth and patient support programs
  • Critical implementation requirements for manufacturers

Whether you are evaluating a new DTP strategy or optimizing for an existing franchise, reach out to learn how our insights can sharpen your planning.

by VS Health Group

About VS Health Group

VS Health Group is a market access and payer engagement firm founded by Bill Finneran, a 35-year industry veteran who helped develop the national account director model at Eli Lilly and co-founded Viking Healthcare Solutions in 1999 — the first outsourced market access team in the pharmaceutical industry. VSHG provides national and regional payer account management, contracting strategy, payer analytics, and market access execution to emerging and established biopharmaceutical companies across all therapeutic categories and benefit types.

Scroll to Top